Anna Grenda Selected Research

Blepharospasm

1/2022

Botulinum toxin in cancer therapy-current perspectives and limitations.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Anna Grenda Research Topics

Disease

22	Neoplasms (Cancer) 01/2024 - 03/2013
15	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2024 - 08/2018
3	Lung Neoplasms (Lung Cancer) 05/2023 - 04/2019
2	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 03/2023 - 01/2021
2	Carcinogenesis 06/2022 - 02/2021
2	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 02/2022 - 01/2017
2	Leukemia 01/2017 - 03/2013
1	Epilepsy (Aura) 03/2023
1	Squamous Cell Carcinoma (Epidermoid Carcinoma) 01/2023
1	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 01/2023
1	Squamous Cell Neoplasms (Squamous Cell Cancer) 01/2023
1	Neoplasm Metastasis (Metastasis) 01/2023
1	Disease Progression 07/2022
1	Diarrhea 06/2022
1	Irritable Bowel Syndrome (Syndrome, Irritable Bowel) 06/2022
1	Botulism 06/2022
1	Chromosome Aberrations (Chromosome Abnormalities) 02/2022
1	Eye Diseases (Eye Disease) 01/2022
1	Adenocarcinoma of Lung 01/2022
1	Blepharospasm 01/2022
1	Movement Disorders (Movement Disorder) 01/2022
1	Muscle Spasticity (Spastic) 01/2022
1	Spasm (Spasms) 01/2022
1	Strabismus (Squint) 01/2022
1	Neutropenia 01/2021
1	Stomach Neoplasms (Stomach Cancer) 11/2020
1	Skin Diseases (Skin Disease) 01/2020
1	Necrosis 01/2020
1	Melanoma (Melanoma, Malignant) 01/2020
1	Trisomy (Trisomies) 01/2017

Drug/Important Bio-Agent (IBA)

6	B7-H1 AntigenIBA 01/2023 - 01/2019
5	MicroRNAs (MicroRNA)IBA 01/2024 - 03/2013
3	Proteins (Proteins, Gene)FDA Link 02/2022 - 11/2020
2	Biomarkers (Surrogate Marker)IBA 01/2024 - 12/2021
2	ErbB Receptors (EGF Receptor)IBA 03/2023 - 08/2018
2	Tyrosine Kinase InhibitorsIBA 03/2023 - 12/2022
2	pembrolizumabIBA 01/2023 - 04/2019
2	alectinibIBA 12/2022 - 01/2022
2	Immune Checkpoint InhibitorsIBA 07/2022 - 09/2017
2	Botulinum Toxins (Botulinum Toxin)IBA 06/2022 - 01/2022
2	Anaplastic Lymphoma KinaseIBA 01/2022 - 08/2018
1	AntibodiesIBA 12/2023
1	LigandsIBA 12/2023
1	Fungal ProteinsIBA 05/2023
1	Microtubule-Associated Proteins (Microtubule-Associated Protein 2)IBA 03/2023
1	Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)IBA 01/2023
1	trametinibIBA 01/2023
1	dabrafenibIBA 01/2023
1	Protein Serine-Threonine Kinases (Protein-Serine-Threonine Kinase)IBA 01/2023
1	MicronutrientsIBA 11/2022
1	Anti-Bacterial Agents (Antibiotics)IBA 06/2022
1	Analgesics (Analgesic Drugs)IBA 01/2022
1	Monoclonal AntibodiesIBA 02/2021
1	Transcription Factors (Transcription Factor)IBA 01/2021
1	Cisplatin (Platino)FDA LinkGeneric 01/2021
1	Etoposide (VP 16)FDA LinkGeneric 01/2021
1	Carboplatin (JM8)FDA LinkGeneric 01/2021
1	PlatinumIBA 01/2021
1	ParaffinIBA 11/2020
1	Formaldehyde (Formol)FDA Link 11/2020
1	carlina oxideIBA 01/2020
1	Phosphotransferases (Kinase)IBA 01/2020
1	Mitogen-Activated Protein Kinase 3IBA 01/2020
1	Antiparasitic Agents (Antiparasitics)IBA 01/2020
1	IpilimumabIBA 04/2019
1	atezolizumabIBA 04/2019
1	Messenger RNA (mRNA)IBA 01/2019

Therapy/Procedure

14	Therapeutics 05/2023 - 03/2013
12	Immunotherapy 01/2024 - 04/2019
4	Drug Therapy (Chemotherapy) 01/2023 - 01/2020
2	Radiotherapy 03/2023 - 01/2022